GZMB and neoplasm: Apart from the direct tumoricidal effects of Doxil, it also displayed various immunomodulatory properties, such as the induction of ICD, the depletion of MDSC (132), and enhanced susceptibility of cancer cells to CTL-released granzyme B (133), all contributing to an elevated anti-tumor immune response (134, 135).